Fidelity Investments’s Transphorm, Inc. Common Stock TGAN Stock Holding History

Fidelity Investments’s Portfolio TGAN Stock Details TGAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-3,172	Closed	-$15.6K	–	5703
2024 Q1	$15.6K	Buy	3,172 +10	+0.3%	+$47	﹤0.01%	4114
2023 Q4	$11.5K	Buy	3,162 +1,584	+100%	+$4.34K	﹤0.01%	4191
2023 Q3	$3.5K	Buy	1,578 +357	+29%	+$997	﹤0.01%	4407
2023 Q2	$4.15K	Buy	1,221 +429	+54%	+$1.55K	﹤0.01%	4414
2023 Q1	$3.16K	Buy	792 +346	+78%	+$1.52K	﹤0.01%	4507
2022 Q4	$2.43K	Sell	446 -440	-50%	-$2.59K	﹤0.01%	4462
2022 Q3	$4K	Buy	886 +843	+1,960%	+$4.15K	﹤0.01%	4425
2022 Q2	$0	Buy	+43	New	+$275	﹤0.01%	5610

Fidelity Investments's TGAN Position: Q2 2024 in Review

Fidelity Investments sold out of Transphorm, Inc. Common Stock (TGAN) in Q2 2024, closing a stake of 3,172 shares — an estimated $15.6K sold.

Fidelity Investments first reported a position in TGAN in Q2 2022 and held it in 8 quarters. The position peaked at $15.6K in Q1 2024. 0 funds tracked by Wall St. Rank hold TGAN as of Q2 2024.

Fidelity Investments reported no remaining Transphorm, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Fidelity Investments sold 3,172 Transphorm, Inc. Common Stock shares in Q2 2024, an estimated $15.6K.
Fidelity Investments first reported a position in Transphorm, Inc. Common Stock in Q2 2022 and held it in 8 quarters.
Fidelity Investments's Transphorm, Inc. Common Stock position peaked at $15.6K in Q1 2024.
0 funds tracked by Wall St. Rank held Transphorm, Inc. Common Stock as of Q2 2024.

Based on Fidelity Investments's 13F filing for Q2 2024, filed 13 Aug 2024.